- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/73 - CD4
Patent holdings for IPC class C07K 14/73
Total number of patents in this class: 296
10-year publication summary
|
11
|
16
|
22
|
22
|
48
|
33
|
37
|
32
|
31
|
17
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4288 |
26 |
| City of Hope | 994 |
18 |
| Mcmaster University | 802 |
16 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2855 |
11 |
| Immatics Biotechnologies GmbH | 1156 |
8 |
| Memorial Sloan-Kettering Cancer Center | 1931 |
6 |
| The Trustees of the University of Pennsylvania | 4323 |
5 |
| University of Florida Research Foundation, Inc. | 4035 |
4 |
| Juno Therapeutics, Inc. | 414 |
4 |
| Shattuck Labs, Inc. | 121 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6428 |
3 |
| Board of Regents, The University of Texas System | 5808 |
3 |
| The Johns Hopkins University | 5675 |
3 |
| Children's National Medical Center | 272 |
3 |
| The Council of the Queensland Institute of Medical Research | 155 |
3 |
| eFFECTOR Therapeutics, Inc. | 69 |
3 |
| International AIDS Vaccine Initiative | 90 |
3 |
| Seattle Children's Hospital (dba Seattle Children's Research Institute) | 182 |
3 |
| Lentigen Technology, Inc. | 100 |
3 |
| 2seventy bio, Inc. | 76 |
3 |
| Other owners | 164 |